Back to GetFilings.com



Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

     
x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the period ended October 31, 2003

OR

     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number 0-6715

ANALOGIC CORPORATION


(Exact name of registrant as specified in its charter)
     
Massachusetts   04-2454372

(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
     
8 Centennial Drive, Peabody, Massachusetts   01960

(Address of principal executive offices)   (Zip Code)

(978) 977-3000


(Registrant’s telephone number, including area code)


(Former name, former address and former fiscal year, if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx Noo

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yesx Noo

The number of shares of Common Stock outstanding at November 28, 2003 was 13,517,281.


ANALOGIC CORPORATION

TABLE OF CONTENTS

Part I. FINANCIAL INFORMATION
ITEM 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Item 4. Controls and Procedures
PART II - OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8 - K
SIGNATURES
EXHIBIT INDEX
EX-31.1 SECTION 302 CERTIFICATION OF C.E.O.
EX-31.2 SECTION 302 CERTIFICATION OF C.F.O.
EX-32.1 SECTION 906 CERTIFICATION OF C.E.O.
EX-32.2 SECTION 906 CERTIFICATION OF C.F.O.


Table of Contents

TABLE OF CONTENTS

             
        Page No.
       
Part I. Financial Information
       
 
Item 1. Financial Statements
       
   
Unaudited Condensed Consolidated Balance Sheets as of October 31, 2003 and July 31, 2003
    3  
   
Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended October 31, 2003 and 2002
    4  
   
Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended October 31, 2003 and 2002
    5  
   
Notes to Unaudited Condensed Consolidated Financial Statements
    6-12  
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    13-21  
 
Item 3. Quantitative and Qualitative Disclosures about Market Risk
    21  
 
Item 4. Controls and Procedures
    21-22  
Part II. Other Information
       
 
Item 6. Exhibits and Reports on Form 8-K
    23  
 
Signatures
    24  
 
Exhibit Index
    25-29  

2


Table of Contents

Part I. FINANCIAL INFORMATION

ITEM 1. Financial Statements

ANALOGIC CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except per share data)

                         
            October 31,   July 31,
            2003   2003
           
 
Assets
               
Current assets:
               
 
Cash and cash equivalents
  $ 130,854     $ 136,806  
 
Marketable securities, at market
    36,456       41,155  
 
Accounts and notes receivable, net of allowance for doubtful accounts of $4,208 at October 31, 2003 and $4,189 at July 31, 2003
    53,385       53,875  
 
Inventories
    71,778       69,548  
 
Costs related to deferred revenue
    16,811       14,796  
 
Refundable and deferred income taxes
    12,804       13,058  
 
Other current assets
    7,946       6,069  
 
 
   
     
 
     
Total current assets
    330,034       335,307  
Property, plant and equipment, net
    87,751       83,926  
Investments in and advances to affiliated companies
    12,570       14,050  
Capitalized software, net
    6,955       6,339  
Goodwill
    2,306       2,306  
Intangible assets, net
    12,722       11,708  
Costs related to deferred revenue
    206       206  
Other assets
    2,390       2,533  
 
 
   
     
 
     
Total Assets
  $ 454,934     $ 456,375  
 
 
   
     
 
Liabilities and Stockholders’ Equity
               
Current liabilities:
               
 
Mortgage and other notes payable
  $ 2,008     $ 1,277  
 
Obligations under capital leases
    173       180  
 
Accounts payable, trade
    19,898       21,162  
 
Accrued liabilities
    20,251       24,412  
 
Deferred revenue
    29,924       30,084  
 
Advanced payments and other
    6,666       5,798  
 
Accrued income taxes
    5,601       5,867  
 
Accrued dividends payable
    1,081          
 
 
   
     
 
     
Total current liabilities
    85,602       88,780  
 
 
   
     
 
Long-term liabilities:
               
 
Mortgage and other notes payable
    3,777       3,837  
 
Obligations under capital leases
    292       327  
 
Deferred revenue
    1,679       1,743  
 
Deferred income taxes
    5,069       5,175  
 
 
   
     
 
     
Total long-term liabilities
    10,817       11,082  
 
 
   
     
 
Commitments and guarantees (Note 13)
               
Stockholders’ equity:
               
 
Common stock, $.05 par
    710       710  
 
Capital in excess of par value
    48,025       47,229  
 
Retained earnings
    319,879       320,328  
 
Accumulated other comprehensive income
    1,702       709  
 
Treasury stock, at cost
    (6,526 )     (6,777 )
 
Unearned compensation
    (5,275 )     (5,686 )
 
 
   
     
 
     
Total stockholders’ equity
    358,515       356,513  
 
 
   
     
 
     
Total Liabilities and Stockholders’ Equity
  $ 454,934     $ 456,375  
 
 
   
     
 

The accompanying notes are an integral part of these unaudited condensed financial statements.

3


Table of Contents

ANALOGIC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share data)

                     
        Three Months Ended
        October 31,
       
        2003   2002
       
 
Net revenue:
               
 
Product
  $ 63,912     $ 123,228  
 
Engineering
    8,621       6,380  
 
Other
    2,436       2,676  
 
 
   
     
 
Total net revenue
    74,969       132,284  
 
 
   
     
 
Cost of sales:
               
 
Product
    39,308       67,633  
 
Engineering
    2,804       4,896  
 
Other
    1,209       1,241  
 
 
   
     
 
Total cost of sales
    43,321       73,770  
 
 
   
     
 
Gross margin
    31,648       58,514  
 
 
   
     
 
Operating expenses:
               
 
Research and product development
    15,303       11,377  
 
Selling and marketing
    8,083       7,934  
 
General and administrative
    8,473       7,833  
 
 
   
     
 
 
    31,859       27,144  
 
 
   
     
 
Income (loss) from operations
    (211 )     31,370  
 
 
   
     
 
Other (income) expense:
               
 
Interest income
    (1,124 )     (1,288 )
 
Interest expense
    73       69  
 
Equity in unconsolidated affiliates
    157       1,238  
 
Other
    (106 )     (343 )
 
 
   
     
 
 
    (1,000 )     (324 )
 
 
   
     
 
Income before income taxes
    789       31,694  
Provision for income taxes
    158       12,044  
 
 
   
     
 
Net income
  $ 631     $ 19,650  
 
 
   
     
 
Net income per common share:
               
   
Basic
  $ 0.05     $ 1.49  
   
Diluted
    0.05       1.48  
Weighted average shares outstanding:
               
   
Basic
    13,381       13,173  
   
Diluted
    13,547       13,252  

The accompanying notes are an integral part of these unaudited condensed financial statements.

4


Table of Contents

ANALOGIC CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)

                     
        Three Months Ended
        October 31,
       
        2003   2002
       
 
OPERATING ACTIVITIES:
               
Net income
  $ 631     $ 19,650  
   
Adjustments to reconcile net income to net cash provided (used) by operating activities:
               
   
Deferred income taxes
    (547 )     (429 )
   
Depreciation and amortization
    5,300       4,341  
   
Allowance for doubtful accounts
    2       685  
   
Loss (gain) on sale of property, plant, and equipment
    (21 )     3  
   
Equity in unconsolidated affiliates
    157       1,238  
   
Compensation expense from stock grants
    411       279  
   
Net changes in operating assets and liabilities
    (8,164 )     (20,159 )
 
   
     
 
NET CASH PROVIDED BY (USED FOR) OPERATING ACTIVITIES:
    (2,231 )     5,608  
 
   
     
 
INVESTING ACTIVITIES:
               
 
Investments in and advances to affiliated companies
    (19 )        
 
Return of investment from affiliated company
            516  
 
Acquisition of businesses, net of cash acquired
    (1,000 )     (1,751 )
 
Additions to property, plant and equipment
    (7,097 )     (6,892 )
 
Capitalized software
    (983 )     (545 )
 
Proceeds from sale of property, plant and equipment
    100       49  
 
Maturities of marketable securities
    4,465       3,685  
 
   
     
 
NET CASH USED FOR INVESTING ACTIVITIES
    (4,534 )     (4,938 )
 
   
     
 
FINANCING ACTIVITIES:
               
 
Payments on debt and capital lease obligations
    (124 )     (103 )
 
Issuance of stock pursuant to exercise of stock options and employee stock purchase plan
    919       137  
 
   
     
 
NET CASH PROVIDED BY FINANCING ACTIVITIES
    795       34  
 
   
     
 
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
    18       (321 )
 
   
     
 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
    (5,952 )     383  
 
   
     
 
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
    136,806       123,168  
 
   
     
 
CASH AND CASH EQUIVALENTS, END OF PERIOD
  $ 130,854     $ 123,551  
 
   
     
 

The accompanying notes are an integral part of these unaudited condensed financial statements.

5


Table of Contents

ANALOGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands except per share data)

1. Basis of presentation:

The unaudited condensed consolidated financial statements of Analogic Corporation (the “Company”) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission for quarterly reports on Form 10-Q and do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary for a fair presentation of the results for all periods presented. The results of operations for the three months ended October 31, 2003, are not necessarily indicative of the results to be expected for the fiscal year ending July 31, 2004, or any other interim period.

These statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended July 31, 2003, included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on October 29, 2003.

The financial statements have not been audited by independent certified public accountants. The condensed consolidated balance sheet as of July 31, 2003, contains data derived from audited financial statements.

Certain financial statement items have been reclassified to conform to the current year’s financial presentation format. The Company reclassified certain intangibles and goodwill balances related to the Company’s 19% ownership of Cedara Software Corporation to investment in and advances to affiliated companies in the Condensed Consolidated Balance Sheets as follows:

                         
    As Reported           Revised
    July 31, 2003   Reclassifications   July 31, 2003
   
 
 
Goodwill
  $ 3,596     $ (1,290 )   $ 2,306  
Intangible assets
    14,891       (3,183 )     11,708  
Investment in and advances to affiliated companies
    9,577       4,473       14,050  

The Company also reclassified in the Condensed Consolidated Statements of Operations the amortization of intangible assets related to Cedara Software Corporation from general and administrative expense to equity in unconsolidated affiliates as follows:

                           
      As Reported           Revised
      October 31, 2002   Reclassifications   October 31, 2002
     
 
 
Operating expenses:
                       
 
General and administrative
  $ 8,085     $ (252 )   $ 7,833  
Other (income) expense:
                       
 
Equity in unconsolidated affiliates
    986       252       1,238  

2. Stock-based compensation:

As permitted by Statement of Financial Accounting Standards No. 148 (“SFAS 148”), “Accounting for Stock-Based Compensation-Transition and Disclosure, an amendment of FASB statement No. 123,” and Statement of Financial Accounting Standards No. 123 (“SFAS 123”) “Accounting for Stock-Based Compensation,” the Company continues to apply the accounting provisions of the Accounting Principle Board (“APB”) No. 25, and related interpretations, with regard to the measurement of compensation cost for options granted under the Company’s equity compensation plans.

6


Table of Contents

ANALOGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Continued)

If the Company had adopted the fair value method described in SFAS 123, the results of operations would have been reported as follows:

                   
      Three Months Ended
      October 31,
     
      2003   2002
     
 
Net income, as reported
  $ 631     $ 19,650  
Add: Stock-based employee compensation expense included in reported net income, net of related tax effects
    329       174  
Deduct: Stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects
    (1,065 )     (1,013 )
 
   
     
 
Pro forma net income (loss)
  $ (105 )   $ 18,811  
 
   
     
 
Earnings (loss) per share:
               
 
Basic-as reported
  $ 0.05     $ 1.49  
 
Basic-pro forma
    (0.01 )     1.43  
 
Diluted-as reported
  $ 0.05     $ 1.48  
 
Diluted-pro forma
    (0.01 )     1.42  

3. Balance sheet information:

     Additional information for certain balance sheet accounts is as follows for the dates indicated:

                   
      October 31,   July 31,
      2003   2003
     
 
Inventories:
               
 
Raw materials
  $ 35,592     $ 37,155  
 
Work-in-process
    13,129       15,003  
 
Finished goods
    23,057       17,390  
 
 
   
     
 
 
  $ 71,778     $ 69,548  
 
 
   
     
 
Accrued liabilities:
               
 
Accrued employee compensation and benefits
  $ 10,238     $ 13,203  
 
Accrued warranty
    6,837       7,302  
 
Other
    3,176       3,907  
 
 
   
     
 
 
  $ 20,251     $ 24,412  
 
 
   
     
 
Advance payments and other:
               
 
Ramp-up funds
  $ 2,860     $ 3,650  
 
Customer deposits
    3,806       2,148  
 
 
   
     
 
 
  $ 6,666     $ 5,798  
 
 
   
     
 

7


Table of Contents

ANALOGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Continued)

4. Business combinations:

On October 20, 2003, Analogic’s 100% owned subsidiary Camtronics Medical Systems acquired certain assets and liabilities from Quinton, Inc. (“QTN”), a Washington corporation, primarily related to intellectual property rights and interests associated with QTN’s Q-Cath hemodynamics and monitoring system business. The Company’s total investment amounted to $1,750, with payments of $1,000 due at closing and $750 due one year from the closing date. In connection with the above transaction, the parties also entered into a Transition Service Agreement and a Cooperative Marketing Agreement. Under the terms of the Transition Service Agreement, QTN has agreed to provide maintenance service to existing and new customers for a period of six months from the closing date. The Cooperative Marketing Agreement, which has a term of four years, provides for QTN to earn up to an additional $1,500 in commissions upon the successful conversion of QTN Q-Cath systems to Camtronics Physiolog and Vericis products. The majority of the purchase price has been included in intangibles assets in the Condensed Consolidated Balance Sheets. The Company is in the process of finalizing the allocation of the purchase price and the estimated useful life of the assets acquired.

5. Investments in and advances to affiliated companies:

Summarized results of operations of the Company’s partially owned equity affiliates are as follows:

                 
    Three Months Ended
    October 31,
   
    2003   2002
   
 
Net revenue
  $ 11,558     $ 5,617  
Gross margin
    6,887       2,766  
Loss from operations
    (362 )     (3,915 )
Net loss
    (477 )     (3,842 )

6. Goodwill and acquired intangible assets:

As of August 1, 2002, Analogic adopted Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets” (“SFAS No. 142”). Under SFAS No. 142, goodwill and certain other intangible assets with indefinite lives are no longer amortized, but instead are reviewed for impairment annually, or more frequently if impairment indicators arise. SFAS No. 142 requires that the Company identify its reporting units and determine the carrying value of each of those reporting units by assigning assets and liabilities, including existing goodwill and intangible assets, to those reporting units. The Company performed its annual goodwill impairment test during the quarter ended October 31, 2003, and determined that goodwill was not impaired. The Company will continue to perform its annual goodwill impairment test during the first quarter of each fiscal year, as well as on an event-driven basis, as required under SFAS No. 142.

Acquired amortizable intangible assets consist of the following:

                                                   
      October 31, 2003   July 31, 2003
     
 
              Accumulated                   Accumulated        
      Cost   Amortization   Net   Cost   Amortization   Net
     
 
 
 
 
 
Amortizable Intangible Assets:
                                               
 
Software Technology
  $ 4,805     $ 1,230     $ 3,575     $ 4,805     $ 1,118     $ 3,687  
 
Intellectual Property
    10,822       1,675       9,147       9,346       1,325       8,021  
 
 
   
     
     
     
     
     
 
 
  $ 15,627     $ 2,905     $ 12,722     $ 14,151     $ 2,443     $ 11,708  
 
 
   
     
     
     
     
     
 

8


Table of Contents

ANALOGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Continued)

The increase of $1,476 in intellectual property relates to intellectual property acquired as part of the Quinton acquisition.

Amortization of acquired intangible assets was $735 and $111 for the three months ended October 31, 2003 and 2002, respectively.

The estimated future amortization expense related to acquired intangible assets in the current fiscal year, and each of the five succeeding fiscal years, is expected to be as follows:

         
2004 (Remaining nine months)
  $ 2,340  
2005
    3,120  
2006
    3,106  
2007
    2,652  
2008
    821  
2009
    683  
 
   
 
 
  $ 12,722  
 
   
 

7. Net income per share:

Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the sum of the weighted average number of common shares outstanding during the period and, if dilutive, the weighted average number of potential shares of common stock, including unvested restricted stock and the assumed exercise of stock options using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share:

                     
        Three Months Ended
        October 31,
       
        2003   2002
       
 
Net income
  $ 631     $ 19,650  
 
   
     
 
Weighted average number of common shares outstanding-basic
    13,381       13,173  
Effect of dilutive securities:
               
   
Stock options and restricted stock
    166       79  
 
   
     
 
Weighted average number of common shares outstanding-diluted
    13,547       13,252  
 
   
     
 
Net income per common share:
               
 
Basic
  $ 0.05     $ 1.49  
 
Diluted
    0.05       1.48  

Options to purchase 34 and 264 shares of common stock with exercise prices greater than the average market price of the Company’s common stock during the three months ended October 31, 2003 and 2002, respectively, were not included in the computation of diluted earnings per share because their inclusion would have been antidilutive.

8. Dividends:

The Company declared dividends of $.08 per common share on October 14, 2003, payable on November 11, 2003 to shareholders of record on October 28, 2003.

9


Table of Contents

ANALOGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Continued)

9. Comprehensive income:

The following table presents the calculation of total comprehensive income and its components:

                 
    Three Months Ended
    October 31,
   
    2003   2002
   
 
Net income
  $ 631     $ 19,650  
Other comprehensive income (loss), net of taxes:
               
Unrealized losses from marketable securities, net of taxes of $92 and $167, for the three months ended October 31, 2003 and 2002, respectively
    (142 )     (254 )
Foreign currency translation adjustment, net of taxes of $744 and $62 for the three months ended October 31, 2003 and 2002, respectively
    1,135       85  
 
   
     
 
Total comprehensive income
  $ 1,624     $ 19,481  
 
   
     
 

10. Supplemental disclosure of cash flow information:

Changes in operating assets and liabilities, net of the impact of acquisitions, are as follows:

                 
    Three Months Ended
    October 31,
   
    2003   2002
   
 
Accounts and notes receivable
  $ 3,346     $ (14,315 )
Accounts receivable from affiliates
    (2,027 )     808  
Inventories
    (1,705 )     (22,106 )
Costs related to deferred revenue
    (2,015 )     (2,401 )
Other current assets
    (1,779 )     329  
Other assets
    1,661       67  
Accounts payable, trade
    (1,403 )     17,066  
Accrued liabilities
    (4,459 )     2,714  
Advance payments and deferred revenue
    509       (14,320 )
Accrued income taxes
    (292 )     11,999  
 
   
     
 
Net changes in operating assets and liabilities
  $ (8,164 )   $ (20,159 )
 
   
     
 

11. Taxes:

The effective tax rate for the first quarter of fiscal 2004 was 20% as compared to 38% for the same period last year. The decrease in the tax rate of 18% was primarily due to estimated benefits from tax exempt interest, extraterritorial income and the research and development credit on a lower dollar base of pretax income for fiscal year 2004 when compared to the first quarter of fiscal 2003.

12. Segment information:

The Company operates in three reporting segments. The two primary reporting segments conduct business within the electronics industry: Imaging Technology Products and Signal Processing Technology Products. Imaging Technology Products consist primarily of electronic systems and subsystems for medical imaging equipment and advanced explosive detection systems. Signal Processing Technology Products consist of Analog to Digital (A/D) converters and supporting modules, and high-speed digital signal processors. The Company’s Corporate and Other segment represents the Company’s hotel business and net interest income.

10


Table of Contents

ANALOGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Continued)

Assets of Corporate and Other consist primarily of the Company’s cash equivalents, marketable securities, fixed and other assets, not specifically identifiable. The table below presents information about the Company’s reportable segments:

                     
        Three Months Ended
        October 31,
       
        2003   2002
       
 
Revenues from external customers:
               
 
Imaging technology products
  $ 66,401     $ 121,955  
 
Signal processing technology products
    6,132       7,653  
 
Corporate and other
    2,436       2,676  
 
 
   
     
 
Total
  $ 74,969     $ 132,284  
 
 
   
     
 
Income (loss) before income taxes:
               
 
Imaging technology products
  $ (492 )   $ 29,534  
 
Signal processing technology products
    (292 )     388  
 
Corporate and other
    1,573       1,772  
 
 
   
     
 
Total
  $ 789     $ 31,694  
 
 
   
     
 
             
        October 31, 2003   July 31, 2003
       
 
Identifiable assets:
               
 
Imaging technology products
  $ 237,843     $ 222,799  
 
Signal processing technology products
    13,687       13,105  
 
Corporate and other (A)
    203,404       220,471  
   
 
   
     
 
Total
  $ 454,934     $ 456,375  
   
 
   
     
 

(A)   Includes cash equivalents and marketable securities of $152,718 and $167,229 at October 31, 2003, and July 31, 2003, respectively.

13. Commitments and guarantees:

During the third quarter of fiscal 2003, the Company commenced the construction of a 100,000 square foot addition to its headquarters building in Peabody, Massachusetts. This two-story addition will enable the Company to further consolidate its existing Massachusetts operations and to expand production capacity for its medical and security imaging system businesses. The building, including fit-up, is estimated to cost approximately $12,500 and will be financed by internally generated cash.

The Company has agreements whereby it indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was serving, at the Company’s request in such capacity. The term of the indemnification period is for the officer’s or director’s lifetime. The potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. Also, to the extent permitted by Massachusetts law, the Company’s Articles of Organization, require the Company to indemnify directors of the Company and the Company’s by-laws require the Company to indemnify the present or former directors and officers of the Company, and also permit indemnification of other employees and agents of the Company for whom the Board of Directors from time to time authorizes indemnification. In no instance, however, will indemnification be granted to a director otherwise entitled thereto who is determined to have (a) committed a breach of loyalty to the Company or its stockholders, (b) committed acts or omissions not in good faith or which involved intentional misconduct or a knowing violation of the law, or (c) derived any improper personal benefit in connection with a particular transaction. Because no claim for indemnification has been made by any person covered by said agreements, and/or the relevant provisions of the Company’s Articles or By-laws, the Company believes that its estimated exposure for these indemnification obligations is currently minimal.

11


Table of Contents

ANALOGIC CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Continued)

Accordingly, the Company has no liabilities recorded for these indemnity agreements and requirements as of October 31, 2003.

The Company’s standard original equipment manufacturing and supply agreements entered into in the ordinary course of business typically contain an indemnification provision pursuant to which the Company indemnifies, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party in connection with any United States patent, or any copyright or other intellectual property infringement claim by any third party with respect to the Company’s products. Such provisions generally survive termination or expiration of the agreements. The potential amount of future payments the Company could be required to make under these indemnification provisions is, in some instances, unlimited. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, the Company believes that its estimated exposure on these agreements is currently minimal. Accordingly, the Company has no liabilities recorded for these agreements as of October 31, 2003.

In fiscal 2002, the Company acquired a 19% interest in Cedara Software Corporation (“Cedara”) of Mississauga, Ontario, Canada. As part of the Company’s investment agreement, the Company has guaranteed certain debt owed by Cedara to its bank lender through the provision of a credit facility with the Company’s principal bank for approximately $11,400 based upon Cedara’s funding requirements. To date, no claims have been asserted against the Company in connection with the guarantee of Cedara’s debt. Accordingly, the Company has no liabilities recorded in connection with the Cedara guarantee as of October 31, 2003.

The Company warrants that its products will perform in all material respects in accordance with its standard published specification in effect at the time of delivery of the products to the customer for a period ranging from 12 to 18 months from the date of delivery. The Company provides for the estimated cost of product and service warranties based on specific warranty claims, claim history and engineering estimates, where applicable. The following table presents the Company’s product warranty liability for the reporting periods:

                 
    Three Months Ended October 31,
    2003   2002
   
 
Balance at the beginning of the period
  $ 7,302     $ 3,235  
Accrual for warranties issued during the period
    735       2,753  
Accrual related to pre-existing warranties (including changes in estimate)
    229       (87 )
Settlements made in cash or in kind during the period
    (1,429 )     (1,197 )
 
   
     
 
Balance at the end of the period
  $ 6,837     $ 4,704  
 
   
     
 

14. Subsequent events:

On December 10, 2003, the Company announced that its Board of Directors, on December 8, 2003, declared dividends of $.08 per common share payable on January 5, 2004 to shareholders of record on December 22, 2003.

12


Table of Contents

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion provides an analysis of the Company’s financial condition and results of operations and should be read in conjunction with the Unaudited Condensed Consolidated Financial Statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q. The discussion below contains forward-looking statements that involve risks and uncertainties. See “Business Environment and Risk Factors” below.

Critical Accounting Policies, Judgments, and Estimates

The U.S. Securities and Exchange Commission (“SEC”) has issued Financial Reporting Release No. 60, “Cautionary Advice Regarding Disclosure About Critical Accounting Policies” (“FRR 60”), suggesting companies provide additional disclosure and commentary on their critical accounting policies. In FRR 60, the SEC defined the most critical accounting policies as the ones that are most important to the portrayal of a company’s financial condition and operating results, and require management to make its most difficult and subjective judgments, often as a result of the need to make estimates of matters that are inherently uncertain. In the case of the Company’s critical accounting policies, these judgments are based on its historical experience, terms of existing contracts, the Company’s observance of trends in the industry, information provided by its customers and information available from other outside sources, as appropriate. The Company’s critical accounting policies include:

Revenue Recognition

The Company recognizes the majority of its revenue in accordance with SEC Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements” (“SAB 101”). Revenue related to product sales is recognized upon shipment provided that title and risk of loss has passed to the customer, there is persuasive evidence of an arrangement, the sales price is fixed or determinable, collection of the related receivable is reasonably assured and customer acceptance criteria, if any, have been successfully demonstrated. For product sales with acceptance criteria that are not successfully demonstrated prior to shipment, revenue is recognized upon customer acceptance provided all other revenue recognition criteria have been met. Hardware maintenance revenues are recognized ratably over the life of the contracts. For business units that sell software licenses, the Company recognizes revenue in accordance with the American Institute of Certified Public Accountants (“AICPA”)’s Statement of Position 97-2, “Software Revenue Recognition” (“SOP 97-2”). The application of SOP 97-2 requires judgment, including whether a software arrangement includes multiple elements, and if so, whether vendor-specific objective evidence (VSOE) of fair value exists for those elements. License revenue is recognized upon delivery, provided that persuasive evidence of an arrangement exists, no significant obligations with regards to installation or implementation remain, fees are fixed or determinable, collectability is reasonably assured and customer acceptance, when applicable, is obtained. Software maintenance revenues are recognized ratably over the life of the contracts. Service revenues are recognized at the time the services are rendered. The Company provides engineering services to some of its customers on a contractual basis and recognizes revenue using the percentage of completion method. The Company estimates the percentage of completion on contracts with fixed fees on a monthly basis utilizing hours incurred to date as a percentage of total estimated hours to complete the project. If the Company does not have a sufficient basis to measure progress towards completion, revenue is recognized upon completion of the contract. When total cost estimates exceed revenues, the Company accrues for the estimated losses immediately. Revenue related to the hotel operations is recognized as services are performed.

Camtronics’ revenues are derived primarily from the sale of Digital Cardiac Information Systems. System sales revenues consist of the following components: computer software licenses, computer hardware, installation support, and sublicensed software. In addition, Camtronics generates revenues related to system sales for software support, hardware maintenance, training, consulting and other professional services.

Camtronics recognizes revenue in accordance with the provisions of SOP 97-2. SOP 97-2 requires revenue earned on software arrangements involving multiple-elements to be allocated to each element based on the fair values of those elements or by use of the residual method. Under the residual method, revenue is recognized in a multiple-element arrangement when company-specific objective evidence of fair value exists for all of the undelivered elements in the arrangement, which is determined by the price charged when that element is sold separately (i.e. professional services, software support, hardware maintenance, hardware and sublicensed software), but does not exist for one or more of the delivered elements in the arrangement (i.e. software solutions). Specifically, Camtronics determines the fair value of the maintenance

13


Table of Contents

portion of the arrangement based on the renewal price of the maintenance charged to clients, professional services portion of the arrangement, other than installation services, based on hourly rates which Camtronics charges for these services when sold apart from a software license, and the hardware and sublicensed software based on the prices for these elements when they are sold separately from the software. If evidence of the fair value cannot be established for the undelivered elements of a license agreement, the entire amount of revenue under the arrangement is deferred until these elements have been delivered or objective evidence of fair value for the remaining undelivered element is established.

Inherent in the revenue recognition process are significant management estimates and judgments, which influence the timing and the amount of revenue recognition. Camtronics provides several models for the procurement of its digital cardiac information systems. The predominant model includes a perpetual software license agreement, project-related installation services, professional consulting services, computer hardware and sub-licensed software and software support.

Camtronics provides installation services, which include project-scoping services, conducting pre-installation audits, detailed installation plans, actual installation of hardware components, and testing of all hardware and software installed at the customer site. Because installation services are deemed to be essential to the functionality of the software, software license and installation services fees are recognized upon completion of installation.

Camtronics also provides professional consulting services, which include consulting activities that fall outside of the scope of the standard installation services. These services vary depending on the scope and complexity requested by the client. Examples of such services may include additional database consulting, system configuration, project management, interfacing to existing systems, and network consulting. Professional consulting services generally are not deemed to be essential to the functionality of the software, and thus, do not impact the timing of the software license revenue recognition. Professional consulting service revenue is recognized as the services are performed.

Hardware and software maintenance fees are marketed under annual and multi-year arrangements and are recognized as revenue ratably over the contracted maintenance term.

Deferred revenue is comprised of 1) license fee, maintenance and other service revenues for which payment has been received and for which services have not yet been performed and 2) revenues related to delivered components of a multiple-element arrangement for which fair value has not been determined for components not yet delivered or accepted by the customer. Deferred costs represent costs related to these revenues; for example, costs of goods sold and services provided and sales commission expenses.

Inventories

The Company values inventory at the lower of cost or market using the first-in, first-out (FIFO) method. Management assesses the recoverability of inventory based on types and levels of inventory held, forecasted demand and changes in technology. These assessments require management judgments and estimates, and valuation adjustments for excess and obsolete inventory may be recorded based on these assessments.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, marketable securities and accounts receivable. The Company places its cash investments and marketable securities in high credit quality financial instruments and, by policy, limits the amount of credit exposure to any one financial institution. The Company grants credit to domestic and foreign original equipment manufacturers, distributors and end users, and performs ongoing credit evaluations on its customer’s financial condition. The Company continuously monitors collections and payments from its customers and maintains a provision for estimated credit losses based upon historical experience and any specific customer collections issues that have been identified. While such credit losses have historically been within expectations and provisions established, there is no guarantee that the Company will continue to experience the same credit loss rates as in the past. Since the accounts receivable are concentrated in a relatively few number of customers, a significant change in liquidity or financial position of any one of these customers could have a material adverse impact on the collectability of accounts receivables and future operating results.

14


Table of Contents

Warranty Reserve

The Company provides for the estimated cost of product warranties at the time products are shipped. Although the Company engages in extensive product quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Should actual product failure rates or service costs differ from the Company’s estimates, which are based on specific warranty claims, historical data and engineering estimates, where applicable, revisions to the estimated warranty liability would be required. Such revisions could adversely affect the Company’s operating results. The Company warrants that its products will perform in all material respects in accordance with its standard published specifications in effect at the time of delivery of the products to the customer for a period ranging for 12 to 18 months from the date of delivery.

Investments in and Advances to Affiliated Companies

The Company has investments in affiliated companies related to areas of the Company’s strategic focus. The Company accounts for these investments using the equity method of accounting. In assessing the recoverability of these investments, the Company must make certain assumptions and judgments based on changes in the Company’s overall business strategy, the financial condition of the affiliated companies, market conditions and the industry and economic environment in which the entity operates. Adverse changes in market conditions or poor operating results of affiliated companies could result in losses or an inability to recover the carrying value of the investments, thereby requiring an impairment charge in the future.

Goodwill, Intangible Assets, and Other Long-Lived Assets

Intangible assets consist of goodwill, intellectual property, licenses, and capitalized software. Other long-lived assets consist primarily of property, plant, and equipment. Intangible assets and property, plant, and equipment, excluding goodwill, are amortized using the straight-line method over their estimated useful life. The carrying value of goodwill and other intangible assets is reviewed on a quarterly basis for the existence of facts and circumstances both internally and externally that may suggest impairment. Factors which the Company considers important and that could trigger an impairment review include significant underperformance relative to expected historical or projected future operating results and significant negative industry or economic trends. The Company determines whether an impairment has occurred based on gross expected future cash flows, and measures the amount of the impairment based on the related future discounted cash flows. The cash flow estimates used to determine impairment, if any, contain management’s best estimates, using appropriate and customary assumptions and projections at the time. In accordance with SFAS No. 142, “Goodwill and Other Intangible Assets,” the Company has ceased amortizing goodwill as of August 1, 2002 and will annually review goodwill for potential impairment during the first quarter of each fiscal year, as well as on an event-driven basis, using a fair value approach.

Income Taxes

As part of the process of preparing the Company’s financial statements, the Company is required to estimate its income taxes in each of the jurisdictions in which it operates. This process involves assessing temporary differences resulting from different treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within the balance sheet. The Company must then assess the likelihood that the deferred tax assets will be recovered from future taxable income and, to the extent that recovery is not more likely than not, a valuation allowance must be established. To the extent a valuation allowance is established, the Company must include an expense within the tax provision in the statement of operations. In the event that actual results differ from these estimates, the provision for income taxes could be materially impacted.

Results of Operations
Three Months Fiscal 2004 (10/31/03) vs. Three Months Fiscal 2003 (10/31/02)

Product revenue for the three months ended October 31, 2003 was $63,912 compared to $123,228 for the same period last year, a decrease of $59,316 or 48%. The decrease in product revenue was primarily due to sales of Imaging Technology Products which decreased $59,796 or 51% to $57,852 for the quarter ended October 31, 2003 from $117,648 for the quarter ended October 31, 2002. The decrease in sales of Imaging Technology Products was primarily the result of a reduction in sales of the EXACT systems and spare parts which the Company supplied to L-3 Communications from $72,966 for the quarter ended October 31, 2002 to $3,300 for the quarter ended October 31, 2003. This was partially offset by increased sales of systems and subsystems for medical imaging equipment.

15


Table of Contents

Engineering revenue for the three months ended October 31, 2003 was $8,621 compared to $6,380 for the same period last year, an increase of $2,241 or 35%. This increase was primarily due to revenue of $2,775 for the sale of a license of intellectual property to the Company’s affiliate Shenzen Anke High-Tech Co. Ltd. (“SAHCO”) related to the manufacturing of anatom whole-body CT systems in China.

Other revenue of $2,436 and $2,676 represents revenue for the hotel operation for the three months ended October 31, 2003 and 2002, respectively.

Cost of product sales was $39,308 for the quarter ended October 31, 2003 compared to $67,633 for the same period last year. Cost of product sales as a percentage of product revenue was 62% and 55% for the three months ended October 31, 2003 and 2002, respectively. The increase in cost of product sales percentage over the prior year quarter was primarily attributable to lower sales of security imaging technology products, which have lower cost of sales then most of the Company’s other products.

Cost of engineering sales was $2,804 for the three months ended October 31, 2003 compared to $4,896 for the same period last year. Cost of engineering sales as a percentage of engineering revenue was 33% and 77% for the three months ended October 31, 2003 and 2002, respectively. The decrease in engineering cost of sales percentage over the prior year was primarily due to the license sale to SAHCO with no corresponding cost, and lower costs related to customer funded projects.

Research and product development expenses were $15,303 for the three months ended October 31, 2003 or 20% of total revenue, compared to $11,377, or 9% of total revenue for the same period last year. The increase of $3,926 was due to the Company continuing to focus substantial resources on developing new generations of medical imaging equipment, including innovative CT systems for niche markets, advanced digital X-ray systems and subsystems for general radiography and mammography, and an extended family of multislice CT Data Acquisition Systems for both medical and security markets. In addition, the Company is developing security-imaging systems for a variety of applications. The Company is in the initial stages of testing prototypes of an automated, CT-based portal screening system that can scan carry-on baggage at airports, “carry-in” baggage at public buildings, and parcels for corporations and delivery services. In addition, the Company continues to increase its investment in a number of other development projects to meet diverse, evolving security needs in the United States and abroad.

Selling and marketing expenses were $8,083 or 11% of total revenue for the three months ended October 31, 2003, as compared to $7,934 or 6% of total revenue for the same period last year. The percentage increase was primarily due to lower revenues than in the same period last year.

General and administrative expenses were $8,473, or 11% of total revenue, for the three months ended October 31, 2003, as compared to $7,833 or 6% of total revenue for the same period last year. The increase of $640 was primarily due to intangible amortization related to acquired intangible assets of $632, and incremental costs due to the acquisition of Sound Technology Inc. and VMI Medical Inc. of $551, partially offset by a reduction in general operating expenses of $543.

Interest income was $1,124 for the three months ended October 31, 2003, compared to $1,288 for the same period last. The decrease was due to lower invested cash balances and effective interest rates.

The Company recorded a loss of $157 and $1,238 related to equity in unconsolidated affiliates for the three months ended October 31, 2003, and 2002, respectively. The loss consists primarily of $128 and $469 reflecting the Company’s share of losses in SAHCO, a gain of $244 versus a loss of $495 reflecting the Company’s share of equity in Cedara Software, for the three months ended October 31, 2003 and 2002, respectively. In addition, the Company recognized expenses of $252 related to the amortization of certain intangibles of Cedara Software, for both the three months ended October 31, 2003 and 2002.

Other income, consisting primarily of currency exchange gain, was $106 and $343 for the three months ended October 31, 2003 and 2002, respectively.

The effective tax rate for the first quarter of fiscal 2004 was 20% as compared to 38% for the same period last year. The decrease in the tax rate of 18% was primarily due to estimated benefits from tax exempt interest, extraterritorial income and the research and development credit on a lower dollar base of pretax income for fiscal year 2004 when compared to the first quarter of fiscal 2003.

Net income for the three months ended October 31, 2003 was $631 or $0.05 per basic and diluted share, as compared to $19,650 or $1.49 per basic share and $1.48 per diluted share for the same period last year. The decrease in net income over the prior year was primarily the result of lower sales of the EXACT systems and associated spare parts.

16


Table of Contents

Liquidity and Capital Resources

The Company’s balance sheet reflects a current ratio of 3.9 to 1 at October 31, 2003 compared to 3.8 to 1 at July 31, 2003. Liquidity is sustained principally through funds provided from operations, with short-term deposits and marketable securities available to provide additional sources of cash. The Company places its cash investments in high credit quality financial instruments and, by policy, limits the amount of credit exposure to any one financial institution. The Company’s debt to equity ratio was .27 to 1 at October 31, 2003 and .28 to 1 at July 31, 2003. The Company believes that its balances of cash and cash equivalents, marketable securities and cash flows expected to be generated by future operating activities will be sufficient to meet its cash requirements over at least the next twelve months.

The Company faces limited exposure to financial market risks, including adverse movements in foreign currency exchange rates and changes in interest rates. These exposures may change over time as business practices evolve and could have a material adverse impact on the Company’s financial results. The Company’s primary exposure has been related to local currency revenue and operating expenses in Canada and Europe.

The carrying amounts reflected in the unaudited condensed consolidated balance sheets of cash and cash equivalents, trade receivables, and trade payables approximate fair value at October 31, 2003, due to the short maturities of these instruments.

The Company maintains a bond investment portfolio of various issuers, types, and maturities. This portfolio is classified on the balance sheet as either cash and cash equivalents or marketable securities, depending on the lengths of time to maturity from original purchase. Cash equivalents include all highly liquid investments with maturities of three months or less from the time of purchase. Investments having maturities from the time of purchase in excess of three months are stated at amortized cost, which approximates fair value, and are classified as available for sale. A rise in interest rates could have an adverse impact on the fair value of the Company’s investment portfolio. The Company does not currently hedge these interest rate exposures.

Cash used in operations was $2,231 for the three months ended October 31, 2003, compared with cash flow generated of $5,608 for the same period last year. The decrease in cash flows from operations was primarily the result of a decrease in net income of $19,019 and a net decrease based on changes in operating assets and liabilities of $11,995.

Net cash used in investing activities was $4,534 for the three months of fiscal 2004 compared to $4,938 for the same period last year. The decrease in net cash used of $404 was primarily due to $780 of marketable securities which matured, partially offset by a reduction in spending of $751 related to business acquisitions, and a reduction of $516 related to return of investment from an affiliated company.

Net cash provided by financing activities was $795 for the three months of fiscal 2004 versus $34 for the prior year period. The increase in cash provided by financing activities of $761 was primarily the result of issuance of stock pursuant to employee stock option and employee stock purchase plans.

The Company’s contractual obligations at October 31, 2003, and the effect such obligations are expected to have on liquidity and cash flows in future periods are as follows:

                                           
              Less then 1           4-5   More than
Contractual Obligations   Total   year   1-3 years   years   5 years

 
 
 
 
 
Mortgage and notes payable
  $ 6,732     $ 2,126     $ 704     $ 704     $ 3,198  
Capital leases
    533       208       277       48          
Operating leases
    9,669       3,290       2,688       1,162       2,529  
Other commitments
    4,675       4,675                          
 
 
   
     
     
     
     
 
 
  $ 21,609     $ 10,299     $ 3,669     $ 1,914     $ 5,727  
 
 
   
     
     
     
     
 

The Company currently has approximately $30,900 in revolving credit facilities with various banks available for direct borrowings. As of October 31, 2003, there were no direct borrowings. However, the Company has guaranteed through a provision of a credit facility with its principal bank the debt owed by Cedara to its bank lender for approximately $11,400.

17


Table of Contents

Business Environment and Risk Factors

   Forward Looking Statements

     This Quarterly Report on Form 10-Q contains statements which, to the extent that they are not recitation of historical facts, constitute “forward-looking statements” pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements, including statements about product development, market and industry trends, strategic initiatives, regulatory approvals, sales, profits, expenses, price trends, research and development expenses and trends, and capital expenditures involve risk and uncertainties, and actual events and results may differ significantly from those indicated in any forward-looking statements as a result of a number of important factors, including those discussed below and elsewhere herein.

   Risk Factors

     You should carefully consider the risks described below before making an investment decision with respect to Analogic Common Stock. Additional risks not presently known to us, or that we currently deem immaterial, may also impair our business. Any of these could have a material and negative effect on our business, financial condition or results of operations.

Because a significant portion of our revenue currently comes from a small number of customers, any decrease in revenue from these customers could harm our operating results.

     We depend on a small number of customers for a large portion of our business, and changes in our customers’ orders may have a significant impact on our operating results. If a major customer significantly reduces the amount of business it does with us, there would be an adverse impact on our operating results. The following table sets forth the percentages of our net product and engineering revenue for our three largest customers in any of the last three fiscal years and the percentage of our total net sales to our ten largest customers in those years:

                                 
  Three Months Ended     Year Ended July 31,  
 
   
 
  October 31, 2003     2003   2002   2001  
 
   
 
 
 
General Electric
  13 %       9 %     12 %     11 %  
Toshiba
  13 %       7 %     5 %     7 %  
Siemens
  9 %       6 %     5 %     4 %  
Philips
  7 %       4 %     18 %     23 %  
L-3 Communications
  5 %       43 %     9 %     1 %  
Ten largest customers as a group
  65 %       77 %     67 %     63 %  

     Although we are seeking to broaden our customer base, we will continue to depend on sales to a relatively small number of major customers. Because it often takes significant time to replace lost business, it is likely that our operating results would be adversely affected if one or more of our major customers were to cancel, delay or reduce significant orders in the future. Our customer agreements typically permit the customer to discontinue future purchases after timely notice.

     In addition, we generate significant accounts receivable in connection with the products we sell and the services we provide to our major customers. Although our major customers are large corporations, if one or more of our customers were to become insolvent or otherwise be unable to pay for our services, our operating results and financial condition could be adversely affected.

Competition from existing or new companies in the medical and security imaging technology industry could cause us to experience downward pressure on prices, fewer customer orders, reduced margins, the inability to take advantage of new business opportunities and the loss of market share.

     We operate in a highly competitive industry. We are subject to competition based upon product design, performance, pricing, quality and services and we believe our innovative engineering and product reliability have been important factors in our growth. While we try to maintain competitive pricing on those products which are directly comparable to products manufactured by others, in many instances our products will conform to more exacting specifications and carry a higher price than analogous products manufactured by others.

     Our competitors include divisions of some larger, more diversified organizations as well as several specialized companies. Some of them have greater resources and larger staffs than we have.

18


Table of Contents

Many of our OEM customers and potential OEM customers have the capacity to design and manufacture the products we manufacture for themselves. We face competition from research and product development groups and the manufacturing operations of our current and potential customers, who continually evaluate the benefits of internal research and product development and manufacturing versus outsourcing.

We depend on our suppliers, some of which are the sole source for our components, and our production would be substantially curtailed if these suppliers are not able to meet our demands and alternative sources are not available.

     We order raw materials and components to complete our customers’ orders, and some of these raw materials and components are ordered from sole-source suppliers. Although we work with our customers and suppliers to minimize the impact of shortages in raw materials and components, we sometimes experience short-term adverse effects due to price fluctuations and delayed shipments. In the past, there have been industry-wide shortages of electronics components. If a significant shortage of raw materials or components were to occur, we might have to delay shipments or pay premium pricing, which could adversely affect our operating results. In some cases, supply shortages of particular components will substantially curtail production of products using these components. We are not always able to pass on price increases to our customers. Accordingly, some raw material and component price increases could adversely affect our operating results. We also depend on a small number of suppliers, some of which are affiliated with customers or competitors and others of which may be small, poorly financed companies, for many of the other raw materials and components that we use in our business. If we are unable to continue to purchase these raw materials and components from our suppliers, our operating results could be adversely affected. Because many of our costs are fixed, our margins depend on our volume of output at our facilities and a reduction in volume could adversely affect our margins.

If we are left with excess inventory, our operating results will be adversely affected.

     Because of long lead times and specialized product designs, we typically purchase components and manufacture products for customer orders or in anticipation of customer orders based on customer forecasts. For a variety of reasons, such as decreased end-user demand for the products we are manufacturing, our customers might not purchase all the products we have manufactured or for which we have purchased components. In either event, we would attempt to recoup our materials and manufacturing costs by means such as returning components to our vendors, disposing of excess inventory through other channels or requiring our OEM customers to purchase or otherwise compensate us for such excess inventory. Some of our significant customer agreements do not give us the ability to require our OEM customers to do this. To the extent we are unsuccessful in recouping our material and manufacturing costs, not only would our net sales be adversely affected, but also our operating results would be disproportionately adversely affected. Moreover, carrying excess inventory would reduce the working capital we have available to continue to operate and grow our business.

Uncertainties and adverse trends affecting our industry or any of our major customers may adversely affect our operating results.

     Our business depends primarily on a specific segment of the electronics industry, medical and security imaging technology products, which is subject to rapid technological change and pricing and margin pressure. This industry has historically been cyclical and subject to significant downturns characterized by diminished product demand, rapid declines in average selling prices and production over-capacity. In addition, changes in government policy relating to reimbursement for the purchase and use of medical and security related capital equipment could also affect our sales. Our customers’ markets are also subject to economic cycles and are likely to experience recessionary periods in the future. The economic conditions affecting our industry in general, or any of our major customers in particular, might adversely affect our operating results. Our businesses outside the medical instrumentation and security technology product sectors are subject to the same or greater technological and cyclical pressures.

Our customers’ delay or inability to obtain any necessary United States or foreign regulatory clearances or approvals for their products could have a material adverse effect on our business.

     Our products are used by a number of our customers in the production of medical devices that are subject to a high level of regulatory oversight. A delay or inability to obtain any necessary United States or foreign regulatory clearances or approvals for products could have a material adverse effect on our business. The process of obtaining clearances and approvals can be costly and time-consuming. There is a further risk that any approvals or clearances, once obtained, may be withdrawn or modified. Medical devices cannot be marketed in the United States without clearance or approval by the FDA. Medical devices sold in the United States must also be manufactured in compliance with FDA rules and regulations, which regulate the design, manufacture, packing, storage and installation of medical devices. Moreover,

19


Table of Contents

medical devices are required to comply with FDA regulations relating to investigational research and labeling. States may also regulate the manufacture, sale and use of medical devices. Medical device products are also subject to approval and regulation by foreign regulatory and safety agencies.

Our business strategy involves the pursuit of acquisitions or business combinations, which may be difficult to integrate, disrupt our business, dilute stockholder value or divert management attention.

     As part of our business strategy, we may consummate additional acquisitions or business combinations. Acquisitions are typically accompanied by a number of risks, including the difficulty of integrating the operations and personnel of the acquired companies, the potential disruption of our ongoing business and distraction of management, expenses related to the acquisition and potential unknown liabilities associated with acquired businesses.

     If we are not successful in completing acquisitions that we may pursue in the future, we may have incurred substantial expenses and devoted significant management time and resources in seeking to complete proposed acquisitions that will not generate benefits for us. In addition, substantial portions of our available cash might be utilized as consideration for these acquisitions.

Our annual and quarterly operating results are subject to fluctuations, which could affect the market price of our Common Stock.

     Our annual and quarterly results may vary significantly depending on various factors, many of which are beyond our control, and may not meet the expectations of securities analysts or investors. If this occurs, the price of our Common Stock would likely decline. These factors include:

    variations in the timing and volume of customer orders relative to our manufacturing capacity;
 
    introduction and market acceptance of our customers’ new products;
 
    changes in demand for our customers’ existing products;
 
    the timing of our expenditures in anticipation of future orders;
 
    effectiveness in managing our manufacturing processes;
 
    changes in competitive and economic conditions generally or in our customers’ markets;
 
    changes in the cost or availability of components or skilled labor;
 
    foreign currency exposure; and
 
    investor and analyst perceptions of events affecting the Company, our competitors and/or our industry.

     As is the case with many technology companies, we typically ship a significant portion of our products in the last month of a quarter. As a result, any delay in anticipated sales is likely to result in the deferral of the associated revenue beyond the end of a particular quarter, which would have a significant effect on our operating results for that quarter. In addition, most of our operating expenses do not vary directly with net sales and are difficult to adjust in the short term. As a result, if net sales for a particular quarter were below our expectations, we could not proportionately reduce operating expenses for that quarter, and, therefore, that revenue shortfall would have a disproportionate adverse effect on our operating results for that quarter.

Loss of any of our key personnel could hurt our business because of their industry experience and their technological expertise.

     We operate in a highly competitive industry and depend on the services of our key senior executives and our technological experts. The loss of the services of one or several of our key employees or an inability to attract, train and retain qualified and skilled employees, specifically engineering and operations personnel, could result in the loss of customers or otherwise inhibit our ability to operate and grow our business successfully.

20


Table of Contents

If we are unable to maintain our technological expertise in research and product development and manufacturing processes, we will not be able to successfully compete.

     We believe that our future success will depend upon our ability to provide research and product development and manufacturing services that meet the changing needs of our customers. This requires that we successfully anticipate and respond to technological changes in design and manufacturing processes in a cost-effective and timely manner. As a result, we continually evaluate the advantages and feasibility of new product design and manufacturing processes. We cannot, however, be certain that our development efforts will be successful.

One stockholder has a substantial interest in Analogic.

     As of November 28, 2003, the Bernard M. Gordon Charitable Remainder Unitrust owned approximately 15% of Analogic’s outstanding Common Stock. Bernard M. Gordon, Chairman of the Board of Directors and Executive Chairman of Analogic, and Julian Soshnick, Vice President of Analogic, serve as trustees of this trust and have full power to vote or dispose of the shares held by the trust. The trust, based on its ownership interest in Analogic, has the ability to exert substantial influence over the actions of Analogic.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

The Company places its cash investments in high credit quality financial instruments and, by policy, limits the amount of credit exposure to any one financial institution. The Company faces limited exposure to financial market risks, including adverse movements in foreign currency exchange rates and changes in interest rates. These exposures may change over time as business practices evolve and could have a material adverse impact on the Company’s financial results. The Company’s primary exposure has been related to local currency revenue and operating expenses in Canada and Europe.

The Company maintains a bond investment portfolio of various issuers, types, and maturities. The Company’s cash and investments include cash equivalents, which the Company considers to be investments purchased with original maturities of three months or less. Investments having original maturities in excess of three months are stated at amortized cost, which approximates fair value, and are classified as available for sale. Total interest income for the three months ended October 31, 2003 was $1,124. An interest rate change of 10% would not have a material impact to the fair value of the portfolio or to future earnings.

The Company’s three largest customers for the fiscal year ended July 31, 2003, each of which is a significant and valued customer, were L-3 Communications, General Electric and Toshiba, which accounted for approximately 43%, 9% and 7%, respectively, of product and engineering revenue. For the first quarter, of fiscal year 2004, ended October 31, 2003, the Company’s three largest customers, General Electric, Toshiba and Siemens accounted for approximately 13%, 13% and 9%, respectively, of product and engineering revenue. Loss of any one of three customers would have a material adverse effect upon the Company’s business.

Item 4. Controls and Procedures

Except as described below, no change in the Company’s internal control over financial reporting occured during the fiscal quarter ended October 31, 2003 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

The Company’s management, with the participation of the Company’s chief executive officer and chief financial officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of October 31, 2003. In designing and evaluating the Company’s disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applied its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on this evaluation, the Company’s chief executive officer and chief financial officer concluded that, as of October 31, 2003, the Company’s disclosure controls and procedures were (1) designed to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to the Company’s chief executive officer and chief financial officer by others within those entities, particularly during the period in which this report was being prepared and (2) effective, in that they provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

In the course of the preparation and audit of the Company’s financial statements for the fiscal year ended July 31, 2003, the Company determined that it had been applying incorrect accounting standards to (1) the recognition of software revenue by Camtronics Medical Systems, Ltd., a 100% owned U.S. subsidiary of the Company, and (2) the treatment of foreign currency exchange gains and losses related to an inter-company loan between the Company and B-K Medical Systems A/S, a 100% owned Danish subsidiary of

21


Table of Contents

the Company. The Company has amended its Annual Reports on Form 10-K for the fiscal years ended July 31, 2001 and 2002, and its Quarterly Reports on Form 10-Q for each of the quarters within the fiscal years ended July 31, 2001, 2002 and 2003, to reflect the appropriate accounting for these transactions. In addition, the Company implemented, during the quarter ended October 31, 2003, the following improvements to its internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) to prevent a reoccurrence of such issues:

    the Company has taken steps to ensure that its financial personnel, particularly those located in the offices of its subsidiaries, fully understand and consistently apply current accounting standards;
 
    the Company has implemented procedures to improve the communications and consultations between the financial officers at the Company’s headquarters and the financial personnel in the offices of its subsidiaries; and
 
    the Company has implemented revised procedures at its Camtronics subsidiary, affecting both sales and marketing personnel and financial personnel, with respect to the structuring and negotiation of customer contracts and the recording of such contracts for accounting purposes.

22


Table of Contents

PART II - OTHER INFORMATION

Item 6. Exhibits and Reports on Form 8 - K

    (a) Exhibits

     
Exhibit   Description

 
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/Rule 15d-16(a) of the Securities Exchange Act of 1934, as amended
     
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    (b)  On October 15, 2003 the Company filed a Current Report on Form 8-K pursuant to which it furnished under item 12 the press release announcing its financial results for the fiscal year ended July 31, 2003.

23


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     
    ANALOGIC CORPORATION
Registrant
     
Date: December 12, 2003   /s/ John W. Wood Jr.
   
    John W. Wood Jr.
    President and Chief Executive Officer
    (Principal Executive Officer)
     
Date: December 12, 2003   /s/ John J. Millerick
   
    John J. Millerick
    Senior Vice President,
    Chief Financial Officer and Treasurer
    (Principal Financial and Accounting Officer)

24


Table of Contents

EXHIBIT INDEX

     
Exhibit   Description

 
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/Rule 15d-15(a) of the Securities Exchange Act of 1934, as amended
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended
     
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

25